PS-001
Type 1/2 Diabetes
Phase 1Active
Key Facts
About Pharmasaga
Taiwanese biotech developing a PDIA4‑inhibitor for type 1/2 diabetes, currently in Phase I trials.
View full company profileType 1/2 Diabetes
Taiwanese biotech developing a PDIA4‑inhibitor for type 1/2 diabetes, currently in Phase I trials.
View full company profile